The correlation between epigenetic aberrations and disease underscores the importance of epigenetic mechanisms. Here, we review recent findings regarding chromatin modifications and their relevance to cancer

Brown, Mark A.

Ducasse, Miryam

Molecular Cancer

English

PubMed

Abstract The correlation between epigenetic aberrations and disease underscores the importance of epigenetic mechanisms. Here, we review recent findings regarding chromatin modifications and their relevance to cancer.</p

Brown Mark A

Ducasse Miryam

Directory of Open Access Journals

Epigenetic aberrations and cancer

Hochschulschriftenserver - Universität Frankfurt am Main

(page number not for citation purposes)

[Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference]. Zhonghua Wai Ke Za Zhi

3rd, Reinberg D: From chromatin to cancer: a new histone lysine methyltransferase enters the mix. Nat Cell Biol

A decade of histone acetylation: marking eukaryotic chromosomes with specific codes.

A genomic code for nucleosome positioning. Nature

A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers. Nat Genet

A: A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer

A: The dMi-2 chromodomains are DNA binding modules important for ATP-dependent nucleosome mobilization. Embo J

AE: Acetylation and Methylation of Histones and Their Possible Role in the Regulation of Rna Synthesis.

Allis CD: RNA meets chromatin. Genes Dev

Allis CD: Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell

Allis CD: The language of covalent histone modifications. Nature

Allis CD: Translating the histone code. Science

AP: Histone contributions to the structure of DNA in the nucleosome.

Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet

Cell cycle-dependent transcription in yeast: promoters, transcription factors, and transcriptomes. Oncogene

Cellular memory and the histone code. Cell

Chiang CM: The general transcription machinery and general cofactors. Crit Rev Biochem Mol Biol

Chromatin and epigenetics in development: blending cellular memory with cell fate plasticity. Development

Chromatin modification and epigenetic reprogramming in mammalian development. Nat Rev Genet

Chromatin remodeling and genome stability. Genome Biol

Chromatin remodeling complexes: ATP-dependent machines in action. Biochem Cell Biol

CL: Nucleosomes, linker DNA, and linker histone form a unique structural motif that directs the higher-order folding and compaction of chromatin.

Croce CM: A microRNA expression signature of human solid tumors defines cancer gene targets.

Croce CM: MicroRNA gene expression deregulation in human breast cancer. Cancer Res

Croce CM: MicroRNAs and leukemias: how strong is the connection? Leuk Res

Deciphering the transcriptional histone acetylation code for a human gene. Cell

Decoding the epigenetic effects of chromatin.

Dent SY: Functions of histone-modifying enzymes in development. Curr Opin Genet Dev

Denu JM: Methyl magic and HAT tricks.

Depinho RA: mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival. Genes Dev

DJ: Small interfering RNA-induced transcriptional gene silencing in human cells. Science

DNA instructed displacement of histones H2A and H2B at an inducible promoter. Mol Cell

DNA methylation in cancer: too much, but also too little. Oncogene

DNA methylation patterns and epigenetic memory. Genes Dev

DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.

Duenas-Gonzalez A: Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study. Mol Cancer

Electron microscopic and biochemical evidence that chromatin structure is a repeating unit. Cell

Epigenetic control in the immune response. Hum Mol Genet

Epigenetic inactivation of the premature aging Werner syndrome gene in human cancer.

Epigenetic programming of differential gene expression in development and evolution. Dev Genet

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker. Drug Resist Updat

Epigenetic treatment of hematopoietic malignancies: in vivo targets of demethylating agents. Semin Oncol

Epigenetics of prostate cancer: beyond DNA methylation.

Epigenomics and epigenetic therapy of cancer. Trends Mol Med

Epimutations in human disease. Curr Top Microbiol Immunol

Establishment and maintenance of DNA methylation patterns in mammals. Curr Top Microbiol Immunol

Factors regulating lactoferrin gene expression.

Festenstein R: Unravelling heterochromatin: competition between positive and negative factors regulates accessibility. Trends Genet

Fundele R: Different molecular mechanisms underlie placental overgrowth phenotypes caused by interspecies hybridization, cloning, and Esx1 mutation. Dev Dyn

Gene expression during terminal erythroid differentiation. Curr Opin Hematol

Gene regulatory networks in the evolution and development of the heart. Science

Genome-wide location analysis: insights on transcriptional regulation. Hum Mol Genet

Genomics: predictable packaging.

Georgel PT: To the 30-nm chromatin fiber and beyond. Biochim Biophys Acta

GL: Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell

Grummt I: The nucleolar remodeling complex NoRC mediates heterochromatin formation and silencing of ribosomal gene transcription. Nat Genet

Grunstein M: Acetylation in histone H3 globular domain regulates gene expression in yeast. Cell

Guarente L: The Sir2 family of protein deacetylases. Annu Rev Biochem

Hake SB: The nucleosome: a little variation goes a long way. Biochem Cell Biol

Harel-Bellan A: Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation. Adv Cancer Res

Hendzel MJ: The relationship between histone H3 phosphorylation and acetylation throughout the mammalian cell cycle. Biochem Cell Biol

Henikoff S: Genome-scale profiling of histone H3.3 replacement patterns. Nat Genet

Henikoff S: The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly. Mol Cell

Herman JG: DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet

Higgs DR: Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation.

Histone acetylases and deacetylases in cell proliferation. Curr Opin Genet Dev

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell

Histone methylation in transcriptional control.

Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum Mol Genet

Horvath CM: Histone deacetylases as transcriptional activators? Role reversal in inducible gene regulation. Sci STKE

Hörz W: ATP-dependent nucleosome remodeling. Annu Rev Biochem

Huang TH: Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers. Clin Cancer Res

HV: Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO-mediated lysozyme repression.

JA: RNA silencing in Drosophila.

JC: Chromatin architectural proteins. Chromosome Res

Jenuwein T: The many faces of histone lysine methylation. Curr Opin Cell Biol

Kamakaka RT: Breaking through to the other side: silencers and barriers. Curr Opin Genet Dev

Kouzarides T: Active genes are tri-methylated at K4 of histone H3. Nature

Kouzarides T: Crosstalk between CARM1 methylation and CBP acetylation on histone H3. Curr Biol

Krebs JE: Functional diversity of ISWI complexes.

Kuilenburg AB: Histone deacetylases (HDACs): characterization of the classical HDAC family.

L: Chromatin modifying activity of leukaemia associated fusion proteins. Hum Mol Genet

Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins. Cancer Biol Ther

Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability. Cell

Lothe RA: A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer

Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev

Madhani HD: Conserved histone variant H2A.Z protects euchromatin from the ectopic spread of silent heterochromatin. Cell

Makunin IV: Non-coding RNA. Hum Mol Genet

Makunin IV: Small regulatory RNAs in mammals.

Mauro E: Histone acetylation in gene regulation. Brief Funct Genomic Proteomic

Mauro E: Role of histone acetylation in the control of gene expression. Biochem Cell Biol

Methyl CpG binding proteins: coupling chromatin architecture to gene regulation. Oncogene

MM: Implication of abnormal epigenetic patterns for human diseases.

MM: Structure and function of protein modules in chromatin biology. Results Probl Cell Differ

Molecular genetics of acute promyelocytic leukemia. Trends Genet

Montecino M: Reduced CpG methylation is associated with transcriptional activation of the bone-specific rat osteocalcin gene in osteoblasts.

MR: Molecular modeling of the chromatosome particle. Nucleic Acids Res

Ohm JE: Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer

Miryam Ducasse is with the Institute for Biomedical Research  Frankfurt, Germany -- Mark A. Brown is with the  Section of Molecular Genetics and Microbiology and Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin TX 78712, USAThe correlation between epigenetic aberrations and disease underscores the importance of epigenetic mechanisms. Here, we review recent findings regarding chromatin modifications and their relevance to cancer.Institute for Cellular and Molecular Biologysambrown750@gmail.co

Texas ScholarWorks

http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1636665

Epigenetic aberrations and cancer

Abstract

Similar works

Full text

Available Versions

Directory of Open Access Journals

Hochschulschriftenserver - Universität Frankfurt am Main

Texas ScholarWorks